Clinical trial
The Impact of Diabetes on REvascularization
NCT03085524 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Diabetes on REvascularization
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- October 1, 2022
- Enrollment
- 215 (actual)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.